O-187 Efficacy and safety of single agent pertuzumab (rhuMAb 2C4), a HER dimerization inhibitor, in Non-Small Cell Lung Cancer (NSCLC) patients after prior chemotherapy
Herbst, R., Davies, A., Johnson, B., Natale, R., Dang, T., Murren, J., Schiller, J., Garland, L., Miller, V., Mendelson, D., Melenevsky, Y., Devries, D., Van Den Abbeele, A., Eberhard, D., Lyons, B.,Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)80321-6
Date:
July, 2005
File:
PDF, 185 KB
english, 2005